Literature DB >> 23186557

Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.

Yvonne Benešová1, Anna Vašků, Pavel Stourač, Magdalena Hladíková, Adam Fiala, Josef Bednařík.   

Abstract

We investigated the HLA-DRB1*1501 tagging rs3135388 gene polymorphism and its association with multiple sclerosis (MS) susceptibility, disability and gender differences. The study group consisted of 306 MS patients and 137 healthy individuals. A significant difference in genotype distribution (Pg=3.06×10(-9)) and allele frequency (Pa=6.08×10(-10)) between MS patients and controls was demonstrated. The homozygotes AA and heterozygotes GA were more frequent in MS patients (OR=4.27, 95% CI: 2.64-6.92). A significant difference between female MS patients and female controls in genotype distribution (Pg=1.3×10(-8)) and allele frequency (Pa=2.82×10(-9)); (OR=5.11, 95% CI: 2.86-9.15) was also proved. Our results indicate that the distribution of the rs3135388 gene polymorphism is a risk factor for MS susceptibility in the Czech female population.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23186557     DOI: 10.1016/j.jneuroim.2012.10.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Mária Bucová; Daniela Čopíková-Cudráková; Jozef Michalík; Karin Gmitterová; Daniel Čierny; Milan Buc; Vladimíra Ďurmanová
Journal:  Folia Microbiol (Praha)       Date:  2017-01-27       Impact factor: 2.099

2.  FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.

Authors:  Patrick K A Kearns; Sarah J Martin; Jessie Chang; Rozanna Meijboom; Elizabeth N York; Yingdi Chen; Christine Weaver; Amy Stenson; Katarzyna Hafezi; Stacey Thomson; Elizabeth Freyer; Lee Murphy; Adil Harroud; Peter Foley; David Hunt; Margaret McLeod; Jonathon O'Riordan; F J Carod-Artal; Niall J J MacDougall; Sergio E Baranzini; Adam D Waldman; Peter Connick; Siddharthan Chandran
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

3.  The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study.

Authors:  Pavel Křenek; Yvonne Benešová; Julie Bienertová-Vašků; Anna Vašků
Journal:  J Mol Neurosci       Date:  2018-03-28       Impact factor: 3.444

4.  Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.

Authors:  Bjørn A Nexø; Palle Villesen; Kari K Nissen; Hanne M Lindegaard; Peter Rossing; Thor Petersen; Lise Tarnow; Bettina Hansen; Tove Lorenzen; Kim Hørslev-Petersen; Sara B Jensen; Shervin Bahrami; Maria Lajer; Kathrine L M Schmidt; Hans-Henrik Parving; Peter Junker; Magdalena J Laska
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

5.  Saliva microbiome, dietary, and genetic markers are associated with suicidal ideation in university students.

Authors:  Angelica P Ahrens; Diego E Sanchez-Padilla; Jennifer C Drew; Monika W Oli; Luiz F W Roesch; Eric W Triplett
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

6.  Alzheimer's Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis.

Authors:  Juraj Javor; Mária Bucová; Vladimíra Ďurmanová; Dominika Radošinská; Zuzana Párnická; Daniel Čierny; Egon Kurča; Daniela Čopíková-Cudráková; Karin Gmitterová; Ivana Shawkatová
Journal:  Life (Basel)       Date:  2022-07-21

Review 7.  Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.

Authors:  Milan Buc
Journal:  Mediators Inflamm       Date:  2013-05-12       Impact factor: 4.711

8.  ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility.

Authors:  Sonia Bourguiba-Hachemi; Tebah K Ashkanani; Fatema J Kadhem; Wassim Y Almawi; Raed Alroughani; M Dahmani Fathallah
Journal:  Mol Med Rep       Date:  2016-08-30       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.